chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Headache, Inappropriate schedule of product administration, Myalgia
Clinical narrative: Severe joint and muscle pain; Severe joint and muscle pain; tiredness; headache; This is a spontaneous report from a contactable consumer (patient) and other HCP. A 71-year-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: FN6200), via an unspecified route of administration, administered in arm left on 28Feb2021 at 09:30 AM (at the age of 71-year-old) as dose 1, single for COVID-19 immunization. The patient medical history included diabetes, hx breast cancer, arthritis and allergy to xray contrast ionic and non-ionic. The patient received concomitant medication in two weeks which included metformin taken for an unspecified indication, start and stop date were not reported. The patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EN6199), via an unspecified route of administration, administered in arm left on 06Mar2021 as dose 2, single for COVID-19 immunization. The patient previously took valium, rocephin and experienced drug allergy. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown whether the patient was diagnosed with COVID prior vaccination. No COVID tested post vaccination. On 05Mar2021, the patient experienced severe joint and muscle pain, tiredness, daily headache about 1 week after 1st injection and continued past 2nd injection up until 12Apr. No treatment was received in response to the adverse events. The outcome of all the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia
Clinical narrative: Other Vaccine same date vaccine date: 06Mar2021; Severe joint and muscle pain, tiredness, daily headache about 1 week after 1st injection and continued past 2nd injection up until 12Apr; Severe joint and muscle pain, tiredness, daily headache about 1 week after 1st injection and continued past 2nd injection up until 12Apr; Severe joint and muscle pain, tiredness, daily headache about 1 week after 1st injection and continued past 2nd injection up until 12Apr; Severe joint and muscle pain, tiredness, daily headache about 1 week after 1st injection and continued past 2nd injection up until 12Apr; This is a spontaneous report from a contactable consumer. A 71-year-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EN6199), dose 2 via an unspecified route of administration, administered in Arm Left on 06Mar2021 as dose 2, single for covid-19 immunisation (at the age of 71-year-old). Medical history included diabetes, hx breast cancer, arthritis from an unknown date and unknown if ongoing, Valium, rocephin, x-ray contrast ionic and non-ionic allergy from an unknown date and unknown if ongoing. Concomitant medications included metformin (MET-FORMIN) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of bnt162b2 (Lot number FN6200) in Arm Left on 28Feb2021 09:30 AM as dose 1, single for covid-19 immunisation and experienced Severe joint and muscle pain, tiredness, daily head-ache. On an unspecified date of Mar2021 patient experienced severe joint and muscle pain, tiredness, daily headache about 1week after 1st injection and continued past 2nd injection up until 12Apr. The treatment was not received. Prior to vaccination, unknown if the patient diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the event was recovered. No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Headache, Inappropriate schedule of product administration, Myalgia
Clinical narrative: Other Vaccine same date vaccine date: 06Mar2021; Severe joint and muscle pain, tiredness, daily headache about 1 week after 1st injection and continued past 2nd injection up until 12Apr; Severe joint and muscle pain, tiredness, daily headache about 1 week after 1st injection and continued past 2nd injection up until 12Apr; Severe joint and muscle pain, tiredness, daily headache about 1 week after 1st injection and continued past 2nd injection up until 12Apr; Severe joint and muscle pain, tiredness, daily headache about 1 week after 1st injection and continued past 2nd injection up until 12Apr; This is a spontaneous report from a contactable consumer. A 71-year-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EN6199), dose 2 via an unspecified route of administration, administered in Arm Left on 06Mar2021 as dose 2, single for covid-19 immunisation (at the age of 71-year-old). Medical history included diabetes, hx breast cancer, arthritis from an unknown date and unknown if ongoing, Valium, rocephin, x-ray contrast ionic and non-ionic allergy from an unknown date and unknown if ongoing. Concomitant medications included metformin (MET-FORMIN) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of bnt162b2 (Lot number FN6200) in Arm Left on 28Feb2021 09:30 AM as dose 1, single for covid-19 immunisation and experienced Severe joint and muscle pain, tiredness, daily head-ache. On an unspecified date of Mar2021 patient experienced severe joint and muscle pain, tiredness, daily headache about 1week after 1st injection and continued past 2nd injection up until 12Apr. The treatment was not received. Prior to vaccination, unknown if the patient diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the event was recovered. No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Anosmia
Clinical narrative: decreased sense of smell; This is a Spontaneous report based on the information received by Pfizer from company (Manufacturer Control No: 2021-0405000266) via a contactable consumer (Patient).  A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: Solution for injection, Lot number and expiry date was not reported), via an unspecified route of administration on 10Mar2021 as dose 1, single for COVID-19 immunization. Medical history included nasal polyps due to which she suffered decreased sense of smell or taste and increased pain/pressure in the face or ears over last month. Concomitant medications were not reported. The patient stated sense of smell returned for 1 month but then disappeared on 13Mar2021 (3 days after taking the Pfizer Covid Vaccine shot). Outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: M
Vaccine: COVID19
Symptoms: Illness, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer or other non healthcare professional. A male patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 09Apr2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fever and got sick causing pyrexia on an unspecified date with outcome of unknown   No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity, Pain of skin
Clinical narrative: He developed hypersensitivity of his skin; Stinging sensation all over his body; This is a spontaneous report from a contactable consumer (patient). A 85-years-old male patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient previously took first dose of bnt162b2 for covid-19 immunisation on an unspecified date for covid-19 immunisation. On an unspecified date, the patient experienced developed hypersensitivity of his skin and stinging sensation all over his body. It was reported that, patient received both doses of the Covid vaccine and reports that no immediate reaction occurred. Reporter stated a couple of weeks after the second dose, on an unspecified date he developed hypersensitivity of his skin, in which he stated that it was bothersome when his pants to touch his legs and he had a stinging sensation all over his body. He stated that he saw a dermatologist, in which they stated that nothing was wrong with his skin and his general practitioner is clueless. He did not have a rash, hives, lesions, warmth, redness, or inflammation. He only had a hypersensitivity, and the vaccine had been the only new thing introduced to his body. He stated that his wife and himself took the vaccine and both doses were spaced more than the recommended period due to an unexpected freeze in (place). He stated that they received their vaccines 4 weeks apart. Reporter asked if there had been any similar reactions reported from the vaccine. Reporter asked how long did the hypersensitivity reactions last, if the reactions occurred immediately or delayed and if Pfizer had any treatment recommendations, if any autoimmune reactions have developed after the vaccine. Seriousness of events were reported as non-serious by the reporter. Outcome of events were unknown.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: having a fever; This is a Spontaneous report from a Pfizer sponsored program Support. A contactable consumer or other non-HCP (wife) reported for patient (Husband). A male patient of an unspecified age received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot Number: not reported), via an unspecified route of administration on 09Apr2021 as DOSE 2, SINGLE for covid-19 immunization. The relevant medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot Number not reported) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunization. On an unspecified date, the patient having a fever. The caller reported that, her husband got the second dose yesterday which is 09Apr2021 and received the first dose 3 weeks ago. Caller did not mention the date of the first dose. Her husband was having a fever and she was getting information if her husband can take Tylenol. Outcome of the event was unknown. No follow-up attempts are possible. Information about lot/batch cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: This is a spontaneous report from a contactable Other Health Professional (patient). A 56-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZ-ER-BIONTECH COVID-19 VACCINE; solution for injection; Batch/Lot Number: EN6202), via an unspecified route of administration, administered in Arm Right on 03Mar2021 at 09:45 AM (at the age of 56-year-old), as DOSE 2, SINGLE for covid-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history included lyme disease from an unknown date and unknown if ongoing. The patient had allergies to clams and Sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other concomitant medications within two weeks. The patient had not received any other vaccine within 4 weeks. Since the vaccination, the patient had not been tested for COVID-19. The patient received first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EL9264), via an unspecified route of administration, administered in Right arm on 09Feb2021 at 09:45 AM (at the age of 56-year-old) for covid-19 immunisation and had Pronounced joint pain with 1st injections, had an exaggeration of L lateral epicondylitis that was present at the time. From there, within 2 days wrist pain became pronounced bilaterally. Joint pain has become far worse in areas of her body that had older injuries and were not in pain at the time of the 1st injection. On an unspecified date in 2021, the patient experienced very pronounced left knee pain and left ankle pain/Currently suffering from right wrist pain. It was reported that after her second Covid 19 vaccination, developed very pronounced left knee pain and left ankle pain. Currently suffering from right wrist pain, exquisitely painful. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Voltaren gel for ankle were taken as a result of very pronounced left knee pain and left ankle pain. The events did not result into death, Life threatening, Caused/prolonged hospitalization, disabling/Incapacitating and congenital anomaly/birth defect. The case was reported as non-serious. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of pronounced left knee pain and left ankle pain/Currently suffering from right wrist pain was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Hypokinesia, Muscle spasms, Pyrexia, Vomiting
Clinical narrative: high fever; vomiting,; sweating; cramps on both hands; couldn't move her hands; This is a spontaneous report from a contactable consumer (husband) from a Pfizer Sponsored Program. A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Unknown), via an unspecified route of administration on 08Apr2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient received the first dose of the Pfizer OVID19 vaccine on 08Apr2021. According to (Name), the patient had some high fever, vomiting, lots of sweating and cramps on both hands this morning (09Apr2021) around 3 am, couldn't move her hands and she couldn't move her hands. Outcome of all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue
Clinical narrative: Joint pain; Tiredness; This is a spontaneous report from a contactable consumer (patient). A 78-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN1318) via an unspecified route of administration, administered in Arm Left on 05Feb2021 (at the age of 77-years-old) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The concomitant medication includes patient was taking other medication (unspecified).On an unspecified date, patient experienced joint pain and tiredness. Consumer stated, "All I want to know is, I want some information okay. Is the tiredness and joint pain been reported before or just I provided. I want to know if it's possible. They said that the COVID Vaccine cause the irritation and symptoms that I am going through right now, is that (incomplete sentence)" No treatment received for adverse event. Patient was taking other medication. consumer stated, "I have had my second dose on 04Mar2021 at arm Left." Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: 104.2 fever lasted for almost 24 hours; This is a spontaneous report from a contactable consumer or other non hcp. A 49-years-old female patient received bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 11Apr2021 10:00(at 49-years of age) as DOSE 1, SINGLE for COVID-19 immunisation.  Medical history included psoriatic arthropathy. Concomitant medication(s) included ustekinumab (STELARA), ibuprofen, pseudoephedrine hydrochloride (ADVIL COLD & SINUS) and pantoprazole. Prior to vaccination, the patient was not diagnosed with COVID-19.Since the vaccination, the patient has not been tested for COVID-19.The patient experienced 104.2 fever lasted for almost 24 hours on 12Apr2021 01:30.The patient underwent lab tests and procedures which included body temperature: 104.2 on 12Apr2021 Adverse event: 104.2 fever lasted for almost 24 hours. No treatment was given for the event.The event outcome was reported as recovered on 13Apr2021 at 01:30. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Erythema, Fatigue, Inflammation, Pain of skin
Clinical narrative: Skin Legions began forming in arm pits and then spread on upper torso.; Skin Legions began forming in arm pits and then spread on upper torso.; The legions are irritating, flat red inflamed about the size of a penny all over front torso.; The legions are irritating, flat red inflamed about the size of a penny all over front torso.; Feeling of something crawling under skin is now sharp stabbing pain on legion areas- like needles poking my body.; Slight exhaustion; This is a spontaneous report received from a contactable consumer (patient). A 50 year-old female non pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: Unknown (Reason: Unable to locate or read the details) via an unspecified route of administration, administered in Arm Left on an unspecified date (Age at Vaccination: 49 year-old) as DOSE 2, SINGLE for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient medical history was not reported. Concomitant medications included tetanus vaccine (TETANUS VACCINE) taken in Arm Right for an unspecified indication on 03Jan2021 (vaccines within 4 weeks prior to the COVID vaccine), other medications the patient received within 2 weeks of vaccination included sertraline hydrochloride (ZOLOFT), alprazolam (XANAX). The patient received other vaccines within 4 weeks prior to the COVID vaccine and Location of injection information was available for it. Prior to vaccination, was the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient previously took compazine [prochlorperazine maleate] and experienced Allergies, took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: Unknown) via an unspecified route of administration, administered in Arm Left on 20Jan2021 at 11:00 AM (Age at Vaccination: 49 year-old) as DOSE 1, SINGLE for COVID-19 immunisation and experienced Heat radiating through body, Skin lesion under left breast, feel sensations under my skin, like insects crawling under skin and Slight exhaustion. After the 2nd dose. Patient stated that her Skin Legions began forming in arm pits and then spread on upper torso. The legions were irritating, flat red inflamed about the size of a penny all over front torso. Had Feeling of something crawling under skin was now sharp stabbing pain on legion areas- like needles poking her body. She had no fever or other side effects, she felt slight exhaustion a few days after initially receiving vaccine. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse events was with Oral steroid and topical prescription lotions. Outcome of events at the time of last observation was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Skin lesion
Clinical narrative: Skin Legions began forming in arm pits and then spread on upper torso.; Skin Legions began forming in arm pits and then spread on upper torso.; The legions are irritating, flat red inflamed about the size of a penny all over front torso.; The legions are irritating, flat red inflamed about the size of a penny all over front torso.; Feeling of something crawling under skin is now sharp stabbing pain on legion areas- like needles poking my body.; Slight exhaustion; This is a spontaneous report received from a contactable consumer (patient). A 50 year-old female non pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: Unknown (Reason: Unable to locate or read the details) via an unspecified route of administration, administered in Arm Left on an unspecified date (Age at Vaccination: 49 year-old) as DOSE 2, SINGLE for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient medical history was not reported. Concomitant medications included tetanus vaccine (TETANUS VACCINE) taken in Arm Right for an unspecified indication on 03Jan2021 (vaccines within 4 weeks prior to the COVID vaccine), other medications the patient received within 2 weeks of vaccination included sertraline hydrochloride (ZOLOFT), alprazolam (XANAX). The patient received other vaccines within 4 weeks prior to the COVID vaccine and Location of injection information was available for it. Prior to vaccination, was the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient previously took compazine [prochlorperazine maleate] and experienced Allergies, took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: Unknown) via an unspecified route of administration, administered in Arm Left on 20Jan2021 at 11:00 AM (Age at Vaccination: 49 year-old) as DOSE 1, SINGLE for COVID-19 immunisation and experienced Heat radiating through body, Skin lesion under left breast, feel sensations under my skin, like insects crawling under skin and Slight exhaustion. After the 2nd dose. Patient stated that her Skin Legions began forming in arm pits and then spread on upper torso. The legions were irritating, flat red inflamed about the size of a penny all over front torso. Had Feeling of something crawling under skin was now sharp stabbing pain on legion areas- like needles poking her body. She had no fever or other side effects, she felt slight exhaustion a few days after initially receiving vaccine. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse events was with Oral steroid and topical prescription lotions. Outcome of events at the time of last observation was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Headache, Myalgia, Trigeminal neuralgia
Clinical narrative: severe muscle aches; headache; some facial nerve type pain; joint soreness; difficult to walk; This is a spontaneous report from a contactable consumer (patient).  A 69-years-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: ER2613), via an unspecified route of administration, administered in left arm on 18Mar2021 at 18:45 (at the age of 69-years) as dose 1, single for covid-19 immunization. The patient medical history included situational depression. The patient had known allergies to sulfa (mild), flagyl and lactose intolerance. The patient previously received morphine and experienced severe itching; received naproxen and experienced stomach pain. The patient was not pregnant at the time of vaccination. The patient concomitant medications included bupropion (BUPROPION) 100 mg per day. The patient had not received any other vaccine within 4 weeks prior vaccination. Following vaccination on an unspecified date in 2021, the patient had experienced severe muscle aches, headache, some facial nerve type pain, joint soreness, difficulty to walk. The headache lasted for 3 days, muscle aches and joint soreness lasted for 2 weeks. The patient had not received any treatment for the events. The patient recovered with lasting effects. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of the events was recovered with sequelae on an unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site pruritus, Nausea, Pain, Pyrexia
Clinical narrative: soreness; had a large bump with itching for a week were shot was injected; I had fever off and on; had a large bump with itching for a week were shot was injected; I was extremely tired; body aches; During the night only I had nausea for a week; This is a spontaneous report from contactable consumer (Patient). A 26-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: unknown) via an unspecified route of administration, administered in left arm on 03Apr2021 at 08:30 (at the age of 26-Year-old) as dose 2, single for COVID-19 immunization.    Medical history was none. There were no concomitant medications in two weeks. Patient had no known allergies.   Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: unknown) via an unspecified route of administration, administered in left arm on 06Mar2021 at 08:30 (at the age of 26-Year-old) as dose 1, single for COVID-19 immunization and experienced within three hours sore arm and within 6 hours waves of being tired. All were gone the next day.     The patient had not received any other vaccine within 4 weeks. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was reported that on 03Apr2021 "soreness within an hour, had a large bump with itching for a week were shot was injected. During that night I had fever off and on (even with taking Tylenol). On an unspecified date in Apr2021(the next day) I was extremely tired and body aches. On an unspecified date in 2021 during the night only I had nausea for a week". Patient received treatment for fever and did not receive any treatment for other adverse events. Outcome of the event was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been requested.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: soreness; had a large bump with itching for a week were shot was injected; I had fever off and on; had a large bump with itching for a week were shot was injected; I was extremely tired; body aches; During the night only I had nausea for a week; This is a spontaneous report from contactable consumer (Patient). A 26-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: unknown) via an unspecified route of administration, administered in left arm on 03Apr2021 at 08:30 (at the age of 26-Year-old) as dose 2, single for COVID-19 immunization.    Medical history was none. There were no concomitant medications in two weeks. Patient had no known allergies.   Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: unknown) via an unspecified route of administration, administered in left arm on 06Mar2021 at 08:30 (at the age of 26-Year-old) as dose 1, single for COVID-19 immunization and experienced within three hours sore arm and within 6 hours waves of being tired. All were gone the next day.     The patient had not received any other vaccine within 4 weeks. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was reported that on 03Apr2021 "soreness within an hour, had a large bump with itching for a week were shot was injected. During that night I had fever off and on (even with taking Tylenol). On an unspecified date in Apr2021(the next day) I was extremely tired and body aches. On an unspecified date in 2021 during the night only I had nausea for a week". Patient received treatment for fever and did not receive any treatment for other adverse events. Outcome of the event was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been requested.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Angiopathy, Inflammation
Clinical narrative: the area that was still inflamed on my hands; enlarged blood vessels, hands, feet, lips and genitals; This is a spontaneous report from a contactable consumer (patient). A 63-year old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: en6205), via an unspecified route of administration in left arm on 04Mar2021 at 13:30 (at the age of 62 years old) as dose 1, single for covid-19 immunisation. Medical history included asthmatic taking montelukast sod 10mg. The patient had known allergies to eggs, nuts, eggplant, some seafood. Concomitant medications included hydrochlorothiazide, losartan potassium (LOSARTAN HCTZ) 25 mg; emtricitabine, tenofovir disoproxil fumarate (EMTRICITABIN TENOFOVIR) 300mg. The patient did not receive any other vaccines within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 07Mar2021 at 12:00 patient experienced enlarged blood vessels, hands, feet, lips and genitals most went back to normal except two vessel on both hands, the second vaccination the same thing happened, but the area that was still inflamed on her hands doubled that has still not reduce but double in size with the second dose. The patient received second dose of BNT162B2 (Lot number: en6205) on 25Mar2021 via an unspecified route of administration in left arm for covid-19 immunisation. The event enlarged blood vessels, hands, feet, lips and genitals resulted in doctor or other healthcare professional office/clinic visit. The patient did not received treatment due to the events. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itchy; This is a spontaneous report from a contactable consumer (patient). A 36-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EP7534) via an unspecified route of administration, administered in Arm Left on 22Mar2021 10:30 (at the age of 36-year-old) as single dose for COVID-19 immunization. Medical history included Asthma, year-round allergies, known allergies to shellfish, fish. No covid prior vaccination. Concomitant medication(s) included levonorgestrel (MIRENA); neomycin; polymyxin b, all taken for an unspecified indication, start and stop date were not reported; Allergy shots. The patient previously took amoxicillin and experienced allergy. It was reported that after first vaccine patient arm was just itchy after. The patient did not receive any treatment for the event. Post vaccination COVID was not tested. The outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pain in extremity
Clinical narrative: soreness of arm (not as severe as 1st dose); severe chills & fever of 101.7°f; severe headache; extreme fatigue the next day.; severe chills & fever of 101.7°f; severe headache; extreme fatigue the next day; severe headache; extreme fatigue the next day; severe headache; extreme fatigue the next day; This is a spontaneous report from a contactable consumer (Patient) via COVID-19 Self-Reporting. A 51-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot Number: EP8734), via an unspecified route of administration, administered in right arm on 07Apr2021 at 10:15 AM (at the age of 51-year-old) as DOSE 2, SINGLE for COVID-19 immunisation at pharmacy. The patient medical history included ongoing breast cancer-dx from 2019 and ongoing treatment with aromatase inhibitor for it, Covid-19 (prior to vaccination) from an unknown date and unknown if ongoing. The patient previously took ciprofloxacin and experienced drug hypersensitivity, Known allergies to cipro antibiotic. Historical Vaccine include bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number: EP7534) via an unspecified route of administration, administered in right arm on 17Mar2021 at 10:15 AM (at the age of 51-year-old) as dose 1 single for COVID-19 immunisation and experienced severe soreness of arm where injected (could not lift arm up for several hours), and experienced mild fever (100°F). The patient concomitant medication(s) (other medications in two weeks) included ARIMIDEX, CALCIUM, and VITAMIN D. The patient did not received any other vaccine in four weeks. There is no COVID tested post vaccination. On 08Apr2021 at 01:30 15 hours 15 minutes after the second dose, the patient experienced soreness of arm (not as severe as 1st dose), severe chills, & fever of 101.7 Fahrenheit. Started, severe headache and extreme fatigue the next day. The patient underwent lab tests and procedures which included on 08Apr2021, body temperature 101.7 Fahrenheit. Treatment not received for the events. Outcome of the events was resolved on an unspecified date in 2021.  No follow up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: soreness of arm (not as severe as 1st dose); severe chills & fever of 101.7°f; severe headache; extreme fatigue the next day.; severe chills & fever of 101.7°f; severe headache; extreme fatigue the next day; severe headache; extreme fatigue the next day; severe headache; extreme fatigue the next day; This is a spontaneous report from a contactable consumer (Patient) via COVID-19 Self-Reporting. A 51-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot Number: EP8734), via an unspecified route of administration, administered in right arm on 07Apr2021 at 10:15 AM (at the age of 51-year-old) as DOSE 2, SINGLE for COVID-19 immunisation at pharmacy. The patient medical history included ongoing breast cancer-dx from 2019 and ongoing treatment with aromatase inhibitor for it, Covid-19 (prior to vaccination) from an unknown date and unknown if ongoing. The patient previously took ciprofloxacin and experienced drug hypersensitivity, Known allergies to cipro antibiotic. Historical Vaccine include bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number: EP7534) via an unspecified route of administration, administered in right arm on 17Mar2021 at 10:15 AM (at the age of 51-year-old) as dose 1 single for COVID-19 immunisation and experienced severe soreness of arm where injected (could not lift arm up for several hours), and experienced mild fever (100°F). The patient concomitant medication(s) (other medications in two weeks) included ARIMIDEX, CALCIUM, and VITAMIN D. The patient did not received any other vaccine in four weeks. There is no COVID tested post vaccination. On 08Apr2021 at 01:30 15 hours 15 minutes after the second dose, the patient experienced soreness of arm (not as severe as 1st dose), severe chills, & fever of 101.7 Fahrenheit. Started, severe headache and extreme fatigue the next day. The patient underwent lab tests and procedures which included on 08Apr2021, body temperature 101.7 Fahrenheit. Treatment not received for the events. Outcome of the events was resolved on an unspecified date in 2021.  No follow up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Nausea
Clinical narrative: I experienced a fever of 100; Chills; Headache; Nausea; Sore arm; Fatigue; The nausea was bad enough to cause me to vomit a number of times.; This is a spontaneous report from a non-contactable consumer (patient). A 62-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration, administered in the left arm on 07Apr2021 at 11:00 as DOSE 2, SINGLE for COVID-19 immunization (at the age of 62-years-old). The patient's medical history was none. The patient was very healthy. The patient had no known allergies. The patient did not receive any medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration, administered in the left arm on 12Mar2021 at 11:00 as DOSE 1, SINGLE for COVID-19 immunization and the patient experienced sore arm. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 23:00, about 12 hours after receiving second dose, the patient experienced a fever of 100°, chills, headache, nausea, sore arm, fatigue and vomiting. This lasted for about 36 hours. It was bad enough to keep the patient in bed the whole while. The nausea was bad enough to cause the patient to vomit a number of times. The events did not result in doctor or other healthcare professional office/clinic visit. No therapeutic measures was taken for the events. The patient underwent lab test and procedures which reported as body temperature at 100° on 07Apr2021. The clinical outcome for the events was reported as recovered on 09Apr2021 at 11:00.   No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Vomiting
Clinical narrative: I experienced a fever of 100; Chills; Headache; Nausea; Sore arm; Fatigue; The nausea was bad enough to cause me to vomit a number of times.; This is a spontaneous report from a non-contactable consumer (patient). A 62-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration, administered in the left arm on 07Apr2021 at 11:00 as DOSE 2, SINGLE for COVID-19 immunization (at the age of 62-years-old). The patient's medical history was none. The patient was very healthy. The patient had no known allergies. The patient did not receive any medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration, administered in the left arm on 12Mar2021 at 11:00 as DOSE 1, SINGLE for COVID-19 immunization and the patient experienced sore arm. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 23:00, about 12 hours after receiving second dose, the patient experienced a fever of 100°, chills, headache, nausea, sore arm, fatigue and vomiting. This lasted for about 36 hours. It was bad enough to keep the patient in bed the whole while. The nausea was bad enough to cause the patient to vomit a number of times. The events did not result in doctor or other healthcare professional office/clinic visit. No therapeutic measures was taken for the events. The patient underwent lab test and procedures which reported as body temperature at 100° on 07Apr2021. The clinical outcome for the events was reported as recovered on 09Apr2021 at 11:00.   No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pain in extremity, Pyrexia
Clinical narrative: Slight sore arm; fever; malaise for 1 day; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 62-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EW0158, Expiration date: unknown), via an unspecified route of administration, administered in Arm Right on 11Apr2021 12:30 (age at vaccination was 62 years) as dose 2, single for COVID-19 immunization. The patient's medical history included obesity, vertigo positional, hypertension, lipids increased, glucose tolerance impaired and covid-19 from Mar2020 to an unknown date. The patient have known allergies. Patient received bisoprolol, atorvastatin calcium (LIPITOR), paracetamol (TYLENOL) and calcium concomitant medications or other medications in two weeks. The patient previously took codeine and experienced pruritus and drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, it was unknown that the patient was diagnosed with COVID-19. Post the vaccination, the patient has not been tested for COVID-19. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EP7534, Expiration date: unknown) via an unspecified route of administration, administered in Arm Right on 21Mar2021 12:30 (age at vaccination was 62 years) as dose 1, single for COVID-19 immunization. After first dose patient experienced Slight sore arm, body aches, fever and malaise. On 11Apr2021 at 19:00, after second dose the patient experienced slight sore arm, fever and malaise for 1 day. No treatment was received for the adverse events. The outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Insomnia, Nausea
Clinical narrative: Intense aches; chills; brain fog; fever; nausea; headache; Couldn't sleep; This is a spontaneous report from a contactable consumer or other non health-care-professional. This consumer reported that a 25-year-old non-pregnant female patient received BNT162B2 (Pfizer COVID 19 Vaccine Formulation: Solution for injection Batch/Lot number: Unknown) via an unspecified route of administration, administered in Left Arm on 31Mar2021 08:30 (Age at vaccination 25 year) as dose 2, single for COVID-19 immunization. Patient previously received Pfizer COVID-19 (Batch/Lot Number: Unknown) administered in Left Arm on 10Mar2021 10:45 AM as dose 1, single for COVID-19 immunization and experienced fatigued. The patient medical history and concomitant medications were not reported. No COVID-19 prior vaccination. Patient had no Known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not tested for COVID-19 post vaccination. Patient states First dose made her fatigue but second dose hit her like a ton of bricks. On 31Mar2021 01:00 PM, patient experienced Intense aches, chills, brain fog, fever, nausea, headache and Couldn't sleep because of the pain. She was a generally very healthy person - this was legitimately the sickest she ever felt. Patient did not receive any treatment for events. Outcome of all events was recovered on an unspecified date in 2021.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Intense aches; chills; brain fog; fever; nausea; headache; Couldn't sleep; This is a spontaneous report from a contactable consumer or other non health-care-professional. This consumer reported that a 25-year-old non-pregnant female patient received BNT162B2 (Pfizer COVID 19 Vaccine Formulation: Solution for injection Batch/Lot number: Unknown) via an unspecified route of administration, administered in Left Arm on 31Mar2021 08:30 (Age at vaccination 25 year) as dose 2, single for COVID-19 immunization. Patient previously received Pfizer COVID-19 (Batch/Lot Number: Unknown) administered in Left Arm on 10Mar2021 10:45 AM as dose 1, single for COVID-19 immunization and experienced fatigued. The patient medical history and concomitant medications were not reported. No COVID-19 prior vaccination. Patient had no Known allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not tested for COVID-19 post vaccination. Patient states First dose made her fatigue but second dose hit her like a ton of bricks. On 31Mar2021 01:00 PM, patient experienced Intense aches, chills, brain fog, fever, nausea, headache and Couldn't sleep because of the pain. She was a generally very healthy person - this was legitimately the sickest she ever felt. Patient did not receive any treatment for events. Outcome of all events was recovered on an unspecified date in 2021.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Dermatitis acneiform, Erythema
Clinical narrative: Small pimple-like red bumps; Small pimple-like red bumps; This is a spontaneous report from a contactable consumer (patient). A 46-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 12Mar2021 at 13:00 (at the age of 46-years) as dose 2, single in the left arm for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no known allergies. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 17Feb2021 at 10:30 (at the age of 46-years) as dose 1, single in the left arm for covid-19 immunisation and experienced upper body, arms, and thighs developed itchy rashes/hives and a number of tiny blood red dots on skin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced upper body (Chest and back) experienced delayed reaction of small pimple-like red bumps on unspecified date. Patient still have these red bumps 1 month after the 2nd shot. Patient visited to doctor or other healthcare professional office/clinic visit. Patient did not receive treatment for events. Patient stated 2 days after the 1st shot my upper body, arms, and thighs developed itchy rashes/hives and a number of tiny blood red dots on my skin. I took antihistamine Allegra D, but it wasn't effective. 10 days later I saw my doctor and was prescribed Triamcinolone Acetonide Cream, which helped to calm my skin inflammation. The rashes slowly faded, but left a few dark colour skin marks. My wife also experienced a minor reaction after her 1st shot. The small lymph node under her jaw was a bit swollen. It hasn't disappeared yet. The outcome of the events was resolved with sequel.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.